Large artery stiffness and antihypertensive agents.

Area of Science:

• Cardiovascular Medicine
• Hypertension Research
• Vascular Biology

Background:

• Peripheral blood pressure monitoring alone is insufficient for complete cardiovascular risk reduction in hypertensive patients.
• Arterial stiffness parameters may offer improved cardiovascular risk assessment and prevention strategies.

Purpose of the Study:

• To review scientific data supporting arterial stiffness parameters as valuable intermediate cardiovascular endpoints.
• To explore optimizing risk assessment and reduction strategies by incorporating arterial stiffness measurements.

Main Methods:

• Systematic review of scientific literature on arterial stiffness and cardiovascular outcomes.
• Analysis of studies investigating aortic pulse wave velocity (PWV) as a predictor.
• Examination of therapeutic trial data and observational studies in hypertensive populations.

Main Results:

• Aortic pulse wave velocity (PWV) is a robust independent predictor of cardiovascular events and mortality across diverse populations.
• Lack of PWV reduction despite blood pressure lowering predicted cardiovascular death in end-stage renal disease.
• Different antihypertensive drug classes show varied effects on central hemodynamics and arterial stiffness.

Conclusions:

• Aortic PWV measurement aids in both cardiovascular risk assessment and risk reduction strategies.
• Monitoring arterial stiffness under various pharmacological regimens can refine treatment approaches.
• Incorporating arterial stiffness assessment can enhance the management of hypertensive patients.